Home | All trials

[RDF data]
Trial NCT00000322

Resource URI: http://static.linkedct.org/resource/trials/NCT00000322
PropertyValue
linkedct:brief_title Tyrosine for Methamphetamine Dependence - 1
linkedct:condition <http://static.linkedct.org/resource/condition/864>
linkedct:criteria Inclusion Criteria: 18-65 years of age. Able to provide informed consent. Desire to reduce/eliminate methamphetamine use. Used within the past two weeks. Meet DSM criteria for methamphetamine dependence. Exclusion Criteria: No dependence (within the past 12 months) for other durgs except nicotine. No history or family history of tyrosine intolerance.
linkedct:description Evaluate efficacy of tyrosine as a treatment for methamphetamine dependence in an outpatient treatment setting providing group psychosocial interventions. Examine effect of tyrosine on abstinence, retention in treatment and craving.
linkedct:download_date Information obtained from ClinicalTrials.gov on December 30, 2009
linkedct:eligibility_gender Both
linkedct:eligibility_healthy_volunteers No
linkedct:eligibility_maximum_age 65 Years
linkedct:eligibility_minimum_age 18 Years
linkedct:end_date December 2001
linkedct:enrollment 89 (xsd:int)
linkedct:firstreceived_date September 20, 1999
linkedct:id NCT00000322
rdfs:label Trial NCT00000322
linkedct:lastchanged_date August 16, 2005
linkedct:lead_sponsor_agency National Institute on Drug Abuse (NIDA)
linkedct:location <http://static.linkedct.org/resource/location/216245>
linkedct:nct_id NCT00000322
linkedct:number_of_arms 0 (xsd:int)
linkedct:number_of_groups 0 (xsd:int)
linkedct:official_title Tyrosine for Methamphetamine Dependence
linkedct:org_study_id NIDA-10739-1
linkedct:overall_official <http://static.linkedct.org/resource/overall_official/19037>
linkedct:overall_status Completed
linkedct:oversight <http://static.linkedct.org/resource/oversight/2918>
foaf:page <http://clinicaltrials.gov/show/NCT00000322>
linkedct:phase Phase 2
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/19100>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/5965>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/7287>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/9333>
linkedct:secondary_id R01-10739-1
linkedct:source National Institute on Drug Abuse (NIDA)
linkedct:start_date April 1997
linkedct:study_design Treatment, Randomized, Double-Blind, Placebo Control
linkedct:study_type Interventional
linkedct:summary The purpose of this study is to evaluate efficacy of tyrosine as a treatment for methamphetamine dependence in an outpatient treatment setting providing group psychosocial interventions. Examine effect of tyrosine on abstinence, retention in treatment, and craving."
rdf:type linkedct:trials
linkedct:verification_date April 1997